Reizine E, Ronot M, Ghosn M, Calderaro J, et al. Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a
biomarker of marked beta-catenin activation in hepatocellular adenoma. Eur Radiol 2020 Nov 4. pii: 10.1007/s00330-020-07434.
PMID: 33146794